Zkusit zdarma
Cogent Biosciences, Inc.

Cogent Biosciences, Inc.

COGT
Cena:
$ 32.67
+0.09 (0.28%)
Valuace
70
Růst
0
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress

Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress

9:30 12-05-2026

WALTHAM, Mass. and BOULDER, Colo., May 12, 2026 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq...

Cogent Biosciences Reports Recent Business Highlights and First Quarter 2026 Financial Results

Cogent Biosciences Reports Recent Business Highlights and First Quarter 2026 Financial Results

8:00 05-05-2026

- Planning for dual launches of bezuclastinib in Systemic Mastocytosis and Gastrointestinal Stromal ...

Cogent Biosciences Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026

Cogent Biosciences Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026

8:00 17-04-2026

– Updated presentation on Cogent's potent pan-KRAS(ON) inhibitor, CGT1263, showcasing its selectiv...

Cogent Biosciences: Blockbuster Potential, Premium Valuation, Still A 'Buy'

Cogent Biosciences: Blockbuster Potential, Premium Valuation, Still A 'Buy'

13:16 02-04-2026

Cogent Biosciences, Inc. maintains a Buy rating as bezuclastinib demonstrates blockbuster potential ...

Head to Head Contrast: Cogent Biosciences (NASDAQ:COGT) versus GT Biopharma (NASDAQ:GTBP)

Head to Head Contrast: Cogent Biosciences (NASDAQ:COGT) versus GT Biopharma (NASDAQ:GTBP)

1:59 02-04-2026

Cogent Biosciences (NASDAQ: COGT - Get Free Report) and GT Biopharma (NASDAQ: GTBP - Get Free Report...

Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST)

Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST)

8:00 01-04-2026

WALTHAM, Mass. and BOULDER, Colo., April 01, 2026 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nas...

This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch

This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch

19:13 21-03-2026

RTW Investments added 4,124,755 Cogent Biosciences shares in the fourth quarter; the estimated trade...

High-Flying Biotech Stock Up 360% Faces $48 Million Trim but Remains This Fund's Largest Holding

High-Flying Biotech Stock Up 360% Faces $48 Million Trim but Remains This Fund's Largest Holding

18:23 21-03-2026

Kynam Capital sold 1,720,949 shares of Cogent Biosciences in the fourth quarter; the estimated trans...

Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026

Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026

12:07 20-03-2026

Boone Capital Management sold 945,042 shares of Cogent Biosciences in the fourth quarter. As a resul...

COGT Rise as FDA Accepts Bezuclastinib NDA in Non-Advanced SM

COGT Rise as FDA Accepts Bezuclastinib NDA in Non-Advanced SM

12:40 17-03-2026

Cogent Biosciences jumps after FDA accepts bezuclastinib NDA for treating non-advanced SM, with a de...

Cogent Biosciences Announces FDA Acceptance of New Drug Application for Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)

Cogent Biosciences Announces FDA Acceptance of New Drug Application for Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)

8:00 16-03-2026

WALTHAM, Mass. and BOULDER, Colo....

Biotech Stock Up 365% as This $8 Million Investment Targets a Drug With 3 NDA Filings Planned

Biotech Stock Up 365% as This $8 Million Investment Targets a Drug With 3 NDA Filings Planned

8:58 13-03-2026

This biotech specializes in precision therapies for rare genetic diseases, with a pipeline targeting...

Cogent Biosciences: Trio Of Approvals Beckon For Lead Drug - Still Bullish

Cogent Biosciences: Trio Of Approvals Beckon For Lead Drug - Still Bullish

14:05 04-03-2026

Cogent Biosciences, Inc. remains a Buy as bezuclastinib advances toward triple approval in GIST and ...

Cogent Biosciences, Inc. (NASDAQ:COGT) Receives Average Recommendation of “Moderate Buy” from Analysts

Cogent Biosciences, Inc. (NASDAQ:COGT) Receives Average Recommendation of “Moderate Buy” from Analysts

2:27 18-02-2026

Cogent Biosciences, Inc. (NASDAQ: COGT - Get Free Report) has earned a consensus recommendation of "...

Cogent Biosciences Stock Soars 346% in a Year, but One Fund Just Sold Off $4.5 Million

Cogent Biosciences Stock Soars 346% in a Year, but One Fund Just Sold Off $4.5 Million

15:28 17-02-2026

Rock Springs Capital Management sold 159,278 shares of Cogent Biosciences in the fourth quarter; the...

Cogent Biosciences Stock Up 346% as Fund Builds $29 Million Stake After November Phase 3 Breakthrough

Cogent Biosciences Stock Up 346% as Fund Builds $29 Million Stake After November Phase 3 Breakthrough

12:38 17-02-2026

First Turn Management acquired 824,283 shares of Cogent Biosciences in the fourth quarter. The quart...

Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results

Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results

8:00 17-02-2026

SUMMIT NDA for bezuclastinib in patients with NonAdvSM submitted in December 2025; APEX NDA submissi...

Cogent Biosciences Announces Multiple SUMMIT Posters at the 2026 AAAAI Annual Meeting

Cogent Biosciences Announces Multiple SUMMIT Posters at the 2026 AAAAI Annual Meeting

8:00 10-02-2026

WALTHAM, Mass. and BOULDER, Colo., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc.  (Nas...

Large Biotech Fund Sells Shares of Cogent Biosciences for Over $120M

Large Biotech Fund Sells Shares of Cogent Biosciences for Over $120M

1:39 01-02-2026

Fairmount Funds Management LLC sold 3,500,000 shares indirectly on Jan. 22, 2026, at $36.40 per shar...

Cogent's New Stomach Cancer Treatment Cuts Progression Risk In Half, Gets Breakthrough Therapy Tag

Cogent's New Stomach Cancer Treatment Cuts Progression Risk In Half, Gets Breakthrough Therapy Tag

10:06 26-01-2026

The FDA granted breakthrough status to Cogent's GIST drug combo after a trial showed it cut disease ...

close

COGENT BIOSCIENCES ANNOUNCES MULTIPLE SUMMIT POSTERS AT THE 2026 AAAAI ANNUAL MEETING

10-02-2026
WALTHAM, MASS. AND BOULDER, COLO., FEB. 10, 2026 (GLOBE NEWSWIRE) -- COGENT BIOSCIENCES, INC.  (NAS...
Více zde

COGENT BIOSCIENCES ANNOUNCES BREAKTHROUGH THERAPY DESIGNATION FOR BEZUCLASTINIB IN COMBINATION WITH SUNITINIB FOR PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS (GIST)

26-01-2026
-   COGENT WILL SUBMIT THE PEAK NEW DRUG APPLICATION (NDA) UNDER PREVIOUSLY ANNOUNCED RTOR DESIGNA...
Více zde

COGENT BIOSCIENCES TO INITIATE NEW DRUG APPLICATION (NDA) SUBMISSION FOR BEZUCLASTINIB UNDER REAL-TIME ONCOLOGY REVIEW (RTOR)

20-01-2026
-  PEAK TRIAL FIRST EVER STUDY TO DEMONSTRATE STATISTICAL SIGNIFICANCE OVER AN ACTIVE COMPARATOR IN...
Více zde

COGENT BIOSCIENCES ANNOUNCES ANTICIPATED 2026 COMMERCIAL AND CLINICAL MILESTONES FOR BEZUCLASTINIB AND PRECISION THERAPIES PORTFOLIO

12-01-2026
WALTHAM, MASS. AND BOULDER, COLO., JAN. 12, 2026 (GLOBE NEWSWIRE) -- COGENT BIOSCIENCES, INC.  (NAS...
Více zde

COGENT BIOSCIENCES ANNOUNCES PRESENTATION AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

06-01-2026
WALTHAM, MASS. AND BOULDER, COLO., JAN. 06, 2026 (GLOBE NEWSWIRE) -- COGENT BIOSCIENCES, INC.  (NAS...
Více zde

COGENT BIOSCIENCES ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION FOR BEZUCLASTINIB IN NONADVANCED SYSTEMIC MASTOCYTOSIS

30-12-2025
WALTHAM, MASS. AND BOULDER, COLO....
Více zde

COGENT BIOSCIENCES PRESENTS FULL SUMMIT RESULTS OF BEZUCLASTINIB IN PATIENTS WITH NONADVANCED SYSTEMIC MASTOCYTOSIS (NONADVSM) AT THE 67TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY (ASH)

06-12-2025
-- BEZUCLASTINIB ACHIEVES CLEAR CLINICAL BENEFIT ACROSS ALL SYMPTOM DOMAINS INCLUDING SIGNIFICANT IM...
Více zde

COGENT BIOSCIENCES ANNOUNCES PARTICIPATION IN THE JEFFERIES GLOBAL HEALTHCARE CONFERENCE

14-11-2025
WALTHAM, MASS. AND BOULDER, COLO., NOV. 14, 2025 (GLOBE NEWSWIRE) -- COGENT BIOSCIENCES, INC. (NASD...
Více zde

COGENT BIOSCIENCES ANNOUNCES PRICING OF CONCURRENT PUBLIC OFFERINGS OF COMMON STOCK AND 1.625% CONVERTIBLE SENIOR NOTES DUE 2031

11-11-2025
WALTHAM, MASS. AND BOULDER, COLO., NOV. 11, 2025 (GLOBE NEWSWIRE) -- COGENT BIOSCIENCES, INC. (“CO...
Více zde

COGENT BIOSCIENCES ANNOUNCES PROPOSED CONCURRENT PUBLIC OFFERINGS OF CONVERTIBLE SENIOR NOTES DUE 2031 AND COMMON STOCK

10-11-2025
WALTHAM, MASS. AND BOULDER, COLO....
Více zde

COGENT BIOSCIENCES REPORTS POSITIVE RESULTS FROM BEZUCLASTINIB PEAK PHASE 3 TRIAL IN GASTROINTESTINAL STROMAL TUMORS (GIST)

10-11-2025
16.5 MONTHS MEDIAN PROGRESSION FREE SURVIVAL (MPFS) FOR BEZUCLASTINIB PLUS SUNITINIB COMPARED TO 9.2...
Více zde

COGENT BIOSCIENCES REPORTS RECENT BUSINESS HIGHLIGHTS AND THIRD QUARTER 2025 FINANCIAL RESULTS

03-11-2025
PHASE 3 PEAK RESULTS IN 2 ND -LINE GIST PATIENTS EXPECTED IN NOVEMBER; PIVOTAL APEX RESULTS IN ADVSM...
Více zde

COGENT BIOSCIENCES ANNOUNCES MULTIPLE PRESENTATIONS AT THE 67TH ANNUAL AMERICAN SOCIETY OF HEMATOLOGY (ASH) MEETING

03-11-2025
SUMMIT DATA FOR BEZUCLASTINIB IN NONADVSM SELECTED FOR TWO ORAL PRESENTATIONS WHICH WILL DESCRIBE IT...
Více zde

COGENT BIOSCIENCES ANNOUNCES KRAS POSTER PRESENTATION AT THE 2025 AACR-NCI-EORTC INTERNATIONAL CONFERENCE ON MOLECULAR TARGETS AND CANCER THERAPEUTICS

24-10-2025
WALTHAM, MASS. AND BOULDER, COLO., OCT. 24, 2025 (GLOBE NEWSWIRE) -- COGENT BIOSCIENCES, INC.  (NAS...
Více zde

COGENT BIOSCIENCES ANNOUNCES FDA BREAKTHROUGH THERAPY DESIGNATION FOR BEZUCLASTINIB

20-10-2025
DETAILED RESULTS FROM BEZUCLASTINIB'S POSITIVE SUMMIT TRIAL EVALUATING BEZUCLASTINIB IN PATIENTS WIT...
Více zde

COGENT BIOSCIENCES REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

29-09-2025
WALTHAM, MASS. AND BOULDER, COLO....
Více zde

COGENT BIOSCIENCES ANNOUNCES PARTICIPATION IN THE CITI BIOPHARMA CONFERENCE

26-08-2025
WALTHAM, MASS. AND BOULDER, COLO....
Více zde

COGENT BIOSCIENCES REPORTS RECENT BUSINESS HIGHLIGHTS AND SECOND QUARTER 2025 FINANCIAL RESULTS

05-08-2025
REPORTED POSITIVE TOP-LINE RESULTS FROM SUMMIT EVALUATING BEZUCLASTINIB IN PATIENTS WITH NONADVANCED...
Více zde

COGENT BIOSCIENCES ANNOUNCES CLOSING OF UPSIZED PUBLIC OFFERING OF SHARES OF COMMON STOCK AND FULL EXERCISE OF UNDERWRITERS' OPTION TO PURCHASE ADDITIONAL SHARES

10-07-2025
WALTHAM, MASS. AND BOULDER, COLO., JULY 10, 2025 (GLOBE NEWSWIRE) -- COGENT BIOSCIENCES, INC. (NASDA...
Více zde

COGENT BIOSCIENCES ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING OF SHARES OF COMMON STOCK

08-07-2025
WALTHAM, MASS. AND BOULDER, COLO., JULY 08, 2025 (GLOBE NEWSWIRE) -- COGENT BIOSCIENCES, INC. (NASD...
Více zde

COGENT BIOSCIENCES ANNOUNCES PROPOSED $150 MILLION PUBLIC OFFERING OF COMMON STOCK

08-07-2025
WALTHAM, MASS. AND BOULDER, COLO., JULY 08, 2025 (GLOBE NEWSWIRE) -- COGENT BIOSCIENCES, INC. (NASD...
Více zde

COGENT BIOSCIENCES ANNOUNCES POSITIVE TOP-LINE RESULTS ACHIEVING STATISTICAL SIGNIFICANCE ACROSS ALL PRIMARY AND KEY SECONDARY ENDPOINTS FROM THE SUMMIT TRIAL OF BEZUCLASTINIB IN PATIENTS WITH NON-ADVANCED SYSTEMIC MASTOCYTOSIS

07-07-2025
-- PATIENTS TREATED WITH BEZUCLASTINIB SHOWED A SUPERIOR MEAN CHANGE IN TOTAL SYMPTOM SCORE AT 24 WE...
Více zde

COGENT BIOSCIENCES SECURES UP TO $400 MILLION IN NON-DILUTIVE FINANCING

11-06-2025
FACILITY PROVIDES ADDITIONAL FUNDING FOR NEXT STEPS OF THE COMPANY'S GROWTH, INCLUDING THE EXPECTED ...
Více zde

COGENT BIOSCIENCES ANNOUNCES PARTICIPATION IN THE JEFFERIES GLOBAL HEALTHCARE CONFERENCE

29-05-2025
WALTHAM, MASS. AND BOULDER, COLO....
Více zde

COGENT BIOSCIENCES REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

06-05-2025
THREE REGISTRATION-DIRECTED TOP-LINE DATA READOUTS REMAIN ON TRACK IN 2025: SUMMIT IN NONADVANCED SM...
Více zde

COGENT BIOSCIENCES PRESENTS FOUR POSTERS AT THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING 2025 AND ANNOUNCES TWO NEW LEADERS

25-04-2025
WALTHAM, MASS. AND BOULDER, COLO....
Více zde

COGENT BIOSCIENCES ANNOUNCES MULTIPLE POSTER PRESENTATIONS AT 2025 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) ANNUAL MEETING

25-03-2025
FOUR ABSTRACTS ACCEPTED FOR POSTER PRESENTATION HIGHLIGHT COGENT'S EXPERTISE IN PIONEERING BEST-IN-C...
Více zde

COGENT BIOSCIENCES ANNOUNCES PARTICIPATION IN THE LEERINK HEALTHCARE CONFERENCE

07-03-2025
WALTHAM, MASS. AND BOULDER, COLO....
Více zde

COGENT BIOSCIENCES ANNOUNCES SUMMIT CONTINUES TO SHOWCASE POWERFUL SYMPTOMATIC IMPROVEMENT IN NONADVANCED SYSTEMIC MASTOCYTOSIS PATIENTS

27-02-2025
65% MEAN IMPROVEMENT IN TOTAL SYMPTOM SCORE (TSS) AT 48 WEEKS, INCLUDING 88% OF PATIENTS ACHIEVING A...
Více zde

COGENT BIOSCIENCES REPORTS RECENT BUSINESS HIGHLIGHTS AND FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS

25-02-2025
• TOP-LINE RESULTS FROM SUMMIT TRIAL IN NONADVSM PATIENTS EXPECTED JULY 2025 •  APEX TRIAL ENRO...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2025-12-08 00:00:008-KStáhnout
2025-11-18 00:00:008-KStáhnout
2025-11-13 00:00:008-KStáhnout
2025-11-10 00:00:008-KStáhnout
2025-11-07 00:00:0010-QStáhnout
2025-11-03 00:00:008-KStáhnout
2025-09-11 01:00:008-KStáhnout
2025-09-11 00:00:008-KStáhnout
2025-08-05 01:00:008-KStáhnout
2025-08-05 01:00:0010-QStáhnout
2025-08-05 00:00:008-KStáhnout
2025-08-05 00:00:0010-QStáhnout
2025-07-10 01:00:008-KStáhnout
2025-07-10 00:00:008-KStáhnout
2025-07-07 01:00:008-KStáhnout
2025-07-07 00:00:008-KStáhnout
2025-06-11 01:00:008-KStáhnout
2025-06-11 00:00:008-KStáhnout
2025-06-05 01:00:008-KStáhnout
2025-06-05 00:00:008-KStáhnout
2025-05-06 01:00:008-KStáhnout
2025-05-06 01:00:0010-QStáhnout
2025-05-06 00:00:008-KStáhnout
2025-05-06 00:00:0010-QStáhnout
2025-02-25 00:00:008-KStáhnout
2025-02-25 00:00:0010-KStáhnout
2025-02-24 23:00:008-KStáhnout
2025-02-24 23:00:0010-KStáhnout
2024-12-09 00:00:008-KStáhnout
2024-12-08 23:00:008-KStáhnout
2024-11-12 00:00:008-KStáhnout
2024-11-12 00:00:0010-QStáhnout
2024-11-11 23:00:008-KStáhnout
2024-11-11 23:00:0010-QStáhnout
2024-09-03 01:00:008-KStáhnout
2024-09-03 00:00:008-KStáhnout
2024-08-06 01:00:008-KStáhnout
2024-08-06 01:00:0010-QStáhnout
2024-08-06 00:00:008-KStáhnout
2024-08-06 00:00:0010-QStáhnout
2024-06-27 01:00:008-KStáhnout
2024-06-27 00:00:008-KStáhnout
2024-06-05 01:00:008-KStáhnout
2024-06-05 00:00:008-KStáhnout
2024-05-07 01:00:008-KStáhnout
2024-05-07 01:00:0010-QStáhnout
2024-05-07 00:00:008-KStáhnout
2024-05-07 00:00:0010-QStáhnout
2024-03-22 00:00:008-KStáhnout
2024-03-21 23:00:008-KStáhnout
2024-02-26 00:00:008-KStáhnout
2024-02-26 00:00:0010-KStáhnout
2024-02-25 23:00:008-KStáhnout
2024-02-25 23:00:0010-KStáhnout
2024-02-14 00:00:008-KStáhnout
2024-02-13 23:00:008-KStáhnout
2023-12-11 00:00:008-KStáhnout
2023-12-10 23:00:008-KStáhnout
2023-11-07 00:00:0010-QStáhnout
2023-11-06 23:00:0010-QStáhnout
2023-11-02 00:00:008-KStáhnout
2023-11-01 23:00:008-KStáhnout
2023-08-08 01:00:008-KStáhnout
2023-08-08 01:00:0010-QStáhnout
2023-08-08 00:00:008-KStáhnout
2023-08-08 00:00:0010-QStáhnout
2023-06-08 01:00:008-KStáhnout
2023-06-08 00:00:008-KStáhnout
2023-06-07 01:00:008-KStáhnout
2023-06-07 00:00:008-KStáhnout
2023-06-06 01:00:008-KStáhnout
2023-06-06 00:00:008-KStáhnout
2023-05-09 01:00:008-KStáhnout
2023-05-09 01:00:0010-QStáhnout
2023-05-09 00:00:008-KStáhnout
2023-05-09 00:00:0010-QStáhnout
2023-03-14 00:00:008-KStáhnout
2023-03-14 00:00:0010-KStáhnout
2023-03-13 23:00:008-KStáhnout
2023-03-13 23:00:0010-KStáhnout
2022-12-12 00:00:008-KStáhnout
2022-12-11 23:00:008-KStáhnout
2022-11-14 00:00:008-KStáhnout
2022-11-14 00:00:0010-QStáhnout
2022-11-13 23:00:008-KStáhnout
2022-11-13 23:00:0010-QStáhnout
2022-08-09 01:00:008-KStáhnout
2022-08-09 01:00:0010-QStáhnout
2022-08-09 00:00:008-KStáhnout
2022-08-09 00:00:0010-QStáhnout
2022-06-15 01:00:008-KStáhnout
2022-06-15 00:00:008-KStáhnout
2022-06-10 01:00:008-KStáhnout
2022-06-10 00:00:008-KStáhnout
2022-05-10 01:00:008-KStáhnout
2022-05-10 01:00:0010-QStáhnout
2022-05-10 00:00:008-KStáhnout
2022-05-10 00:00:0010-QStáhnout
2022-05-06 01:00:008-KStáhnout
2022-05-06 00:00:008-KStáhnout
2022-03-15 00:00:008-KStáhnout
2022-03-15 00:00:0010-KStáhnout
2022-03-14 23:00:008-KStáhnout
2022-03-14 23:00:0010-KStáhnout
2021-12-27 00:00:008-KStáhnout
2021-12-26 23:00:008-KStáhnout
2021-11-10 00:00:008-KStáhnout
2021-11-10 00:00:0010-QStáhnout
2021-11-09 23:00:008-KStáhnout
2021-11-09 23:00:0010-QStáhnout
2021-08-16 01:00:008-KStáhnout
2021-08-16 01:00:0010-QStáhnout
2021-08-16 00:00:008-KStáhnout
2021-08-16 00:00:0010-QStáhnout
2021-07-09 01:00:008-KStáhnout
2021-07-09 00:00:008-KStáhnout
2021-06-17 01:00:008-KStáhnout
2021-06-17 00:00:008-KStáhnout
2021-05-12 01:00:008-KStáhnout
2021-05-12 01:00:0010-QStáhnout
2021-05-12 00:00:008-KStáhnout
2021-05-12 00:00:0010-QStáhnout
2021-03-16 00:00:008-KStáhnout
2021-03-16 00:00:0010-KStáhnout
2021-03-15 23:00:008-KStáhnout
2021-03-15 23:00:0010-KStáhnout
2021-02-22 00:00:008-KStáhnout
2021-02-21 23:00:008-KStáhnout
2020-12-02 00:00:008-KStáhnout
2020-12-01 23:00:008-KStáhnout
2020-11-30 00:00:008-KStáhnout
2020-11-29 23:00:008-KStáhnout
2020-11-09 00:00:008-KStáhnout
2020-11-09 00:00:0010-QStáhnout
2020-11-08 23:00:008-KStáhnout
2020-11-08 23:00:0010-QStáhnout
2020-10-26 00:00:008-KStáhnout
2020-10-25 23:00:008-KStáhnout
2020-10-23 01:00:008-KStáhnout
2020-10-23 00:00:008-KStáhnout
2020-10-05 01:00:008-KStáhnout
2020-10-05 00:00:008-KStáhnout
2020-09-03 01:00:008-KStáhnout
2020-09-03 00:00:008-KStáhnout
2020-08-11 01:00:008-KStáhnout
2020-08-11 01:00:0010-QStáhnout
2020-08-11 00:00:008-KStáhnout
2020-08-11 00:00:0010-QStáhnout
2020-08-10 01:00:008-KStáhnout
2020-08-10 00:00:008-KStáhnout
2020-07-06 01:00:008-KStáhnout
2020-07-06 00:00:008-KStáhnout
2020-06-10 01:00:008-KStáhnout
2020-06-10 00:00:008-KStáhnout
2020-05-15 01:00:008-KStáhnout
2020-05-15 00:00:008-KStáhnout
2020-05-11 01:00:008-KStáhnout
2020-05-11 01:00:0010-QStáhnout
2020-05-11 00:00:008-KStáhnout
2020-05-11 00:00:0010-QStáhnout
2020-03-26 00:00:008-KStáhnout
2020-03-26 00:00:0010-KStáhnout
2020-03-25 23:00:008-KStáhnout
2020-03-25 23:00:0010-KStáhnout
2020-03-20 00:00:008-KStáhnout
2020-03-19 23:00:008-KStáhnout
2020-03-16 00:00:008-KStáhnout
2020-03-15 23:00:008-KStáhnout
2020-03-10 00:00:008-KStáhnout
2020-03-09 23:00:008-KStáhnout
2020-03-09 00:00:008-KStáhnout
2020-03-08 23:00:008-KStáhnout
2020-03-02 00:00:008-KStáhnout
2020-03-01 23:00:008-KStáhnout
2020-01-29 00:00:008-KStáhnout
2020-01-28 23:00:008-KStáhnout
2020-01-17 00:00:008-KStáhnout
2020-01-16 23:00:008-KStáhnout
2020-01-13 00:00:008-KStáhnout
2020-01-12 23:00:008-KStáhnout
2020-01-06 00:00:008-KStáhnout
2020-01-05 23:00:008-KStáhnout
2019-12-09 00:00:008-KStáhnout
2019-12-08 23:00:008-KStáhnout
2019-11-12 00:00:008-KStáhnout
2019-11-12 00:00:0010-QStáhnout
2019-11-11 23:00:008-KStáhnout
2019-11-11 23:00:0010-QStáhnout
2019-11-05 00:00:008-KStáhnout
2019-11-04 23:00:008-KStáhnout
2019-11-04 00:00:008-KStáhnout
2019-11-03 23:00:008-KStáhnout
2019-08-12 01:00:008-KStáhnout
2019-08-12 01:00:0010-QStáhnout
2019-08-12 00:00:008-KStáhnout
2019-08-12 00:00:0010-QStáhnout
2019-08-05 01:00:008-KStáhnout
2019-08-05 00:00:008-KStáhnout
2019-07-29 01:00:008-KStáhnout
2019-07-29 00:00:008-KStáhnout
2019-07-25 01:00:008-KStáhnout
2019-07-25 00:00:008-KStáhnout
2019-07-02 01:00:008-KStáhnout
2019-07-02 00:00:008-KStáhnout
2019-06-25 01:00:008-KStáhnout
2019-06-25 00:00:008-KStáhnout
2019-06-18 01:00:008-KStáhnout
2019-06-18 00:00:008-KStáhnout
2019-06-14 01:00:008-KStáhnout
2019-06-14 00:00:008-KStáhnout
2019-05-13 01:00:008-KStáhnout
2019-05-13 01:00:0010-QStáhnout
2019-05-13 00:00:008-KStáhnout
2019-05-13 00:00:0010-QStáhnout
2019-03-28 00:00:008-KStáhnout
2019-03-28 00:00:0010-KStáhnout
2019-03-27 23:00:008-KStáhnout
2019-03-27 23:00:0010-KStáhnout
2019-03-07 00:00:008-KStáhnout
2019-03-06 23:00:008-KStáhnout
2019-01-23 00:00:008-KStáhnout
2019-01-22 23:00:008-KStáhnout
2019-01-07 00:00:008-KStáhnout
2019-01-06 23:00:008-KStáhnout
2019-01-03 00:00:008-KStáhnout
2019-01-02 23:00:008-KStáhnout
2018-12-03 00:00:008-KStáhnout
2018-12-02 23:00:008-KStáhnout
2018-11-13 00:00:008-KStáhnout
2018-11-13 00:00:0010-QStáhnout
2018-11-12 23:00:008-KStáhnout
2018-11-12 23:00:0010-QStáhnout
2018-08-13 01:00:008-KStáhnout
2018-08-13 01:00:0010-QStáhnout
2018-08-13 00:00:008-KStáhnout
2018-08-13 00:00:0010-QStáhnout
2018-05-14 01:00:008-KStáhnout
2018-05-14 01:00:0010-QStáhnout
2018-05-14 00:00:008-KStáhnout
2018-05-14 00:00:0010-QStáhnout
preloader